title: [Obtaining of the affinity purified antibodies against survivin for the structure functional study of the protein].
abstract: Tumor-associated protein survivin is the bifunctional protein which can participate either in cell division regulation or in apoptosis inhibition depending on its localization and structure state. The aim of this work was to obtain monospecific antibodies useful for investigation of protein structure and functional features. Six affinity purified antibodies directed to different protein regions were obtained. The ability of antibodies obtained to detect survivin in tumor cells and breast cancer tissues was studied. It was shown that antibodies to (1-22) and (95-105) survivin fragments have the highest specific activity. In western-blot antibodies to (1-22) region predominantly binds with survivin-containing complex, which may be the survivin dimer as we suppose, while antibodies to (95-105) region detects only monomeric form of the protein. Breast cancer tissues study demonstrated that survivin monomer presents only in the tumor core tissues, while survivin-containing complex is expressed both in tumor core and tumor periphery tissues. It was shown that antibodies to (1-22) fragment detect predominantly nuclear survivin, which participates in mitosis regulation, while antibodies to (95-105) fragment gave nucleoplasm and cytoplasm staining at all stages of cell cycle. Thereby antibodies obtained are the useful tool for structure-functional study of survivin.
authors.forename: E V
authors.initials: EV
authors.lastname: Akhidova
authors.forename: T D
authors.initials: TD
authors.lastname: Volkova
authors.forename: D O
authors.initials: DO
authors.lastname: Koroev
authors.forename: I Iu
authors.initials: IIu
authors.lastname: Yakupov
authors.forename: M V
authors.initials: MV
authors.lastname: Kalintseva
authors.forename: L E
authors.initials: LE
authors.lastname: Zavalishina
authors.forename: A P
authors.initials: AP
authors.lastname: Kaplun
authors.forename: O O
authors.initials: OO
authors.lastname: Zharskaia
authors.forename: O V
authors.initials: OV
authors.lastname: Zatsepina
authors.forename: O M
authors.initials: OM
authors.lastname: Vol'pina
mesh_terms: D000906:Antibodies / Q000737:chemistry / Q000276:immunology*; D000915:Antibody Affinity / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology* / Q000473:pathology; D005260:Female; D006367:HeLa Cells; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000737:chemistry / Q000276:immunology*; D010455:Peptides / Q000737:chemistry / Q000276:immunology* / Q000302:isolation & purification; D000077022:Survivin
chemical_list: D000906:Antibodies; C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D010455:Peptides; D000077022:Survivin